Adverse events and responses in patients with recurrent ovarian cancer undergoing early-phase immune checkpoint inhibitor clinical trials
Year: 2018
Type: article
Source: Gynecologic Oncology
Authors: E.M. Hinchcliff, D. Hong, H. Le, G. Chisholm, R. Iyer, A. Naing, A.A. Jazaeri
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2811410940
